82 related articles for article (PubMed ID: 20506778)
1. [Sex as a prognostic factor for the patients with non-small cell lung cancer].
Uchikov A; Dimitrov I; Uchikova E; Prisadov G; Grigorov D; Staribratova D; Novakov I
Khirurgiia (Sofiia); 2009; (6):37-9. PubMed ID: 20506778
[TBL] [Abstract][Full Text] [Related]
2. [Stage of disease as a prognostic factor in radically operated patients with non-small cell lung cancer].
Uchikov A; Hadjiev B; Dimitrov I; Murdjev K; Grudeva-Popova J; Prisadov G; Uchikova E; Paskalev G
Khirurgiia (Sofiia); 2010; (2-3):8-11. PubMed ID: 21972687
[TBL] [Abstract][Full Text] [Related]
3. [Histoligic type of the tumor as an independent factor for survival in non-small cell lung cancer].
Uchikov A; Staribratova D; Prisadov G; Uchikova E; Dimitrov I; Batashki A
Khirurgiia (Sofiia); 2009; (4-5):24-6. PubMed ID: 20506801
[TBL] [Abstract][Full Text] [Related]
4. [Extent of resection as a prognostic factor in patients with non-small cell lung cancer].
Uchikov A; Dimitrov I; Hadjiev B; Grudeva-Popova J; Prisadov G; Uchikova E; Uzunova V; Paskalev G
Khirurgiia (Sofiia); 2010; (2-3):15-8. PubMed ID: 21972689
[TBL] [Abstract][Full Text] [Related]
5. ["M"-category as a prognostic factor in operated patients with non-small cell lung cancer].
Uchikov A; Prisadov G; Uchikova E; Dimitrov I; Iankulov A; Batashki A
Khirurgiia (Sofiia); 2009; (4-5):16-8. PubMed ID: 20506799
[TBL] [Abstract][Full Text] [Related]
6. The prognostic impact of sex on surgically resected non-small cell lung cancer depends on clinicopathologic characteristics.
Sterlacci W; Tzankov A; Veits L; Oberaigner W; Schmid T; Hilbe W; Fiegl M
Am J Clin Pathol; 2011 Apr; 135(4):611-8. PubMed ID: 21411784
[TBL] [Abstract][Full Text] [Related]
7. [Prognostic value of estrogen receptors--ERalpha and ERbeta, in patients with lung cancer].
Uchikov A; Dimitrov I; Hadjiev B; Prisadov G; Uchikova E; Ganchevska P; Uzunova V
Khirurgiia (Sofiia); 2010; (1):32-5. PubMed ID: 21972702
[TBL] [Abstract][Full Text] [Related]
8. The serum ferritin concentration is a significant prognostic indicator of survival in primary lung cancer.
Milman N; Pedersen LM
Oncol Rep; 2002; 9(1):193-8. PubMed ID: 11748482
[TBL] [Abstract][Full Text] [Related]
9. [Recurrence and survival after surgical treatment of lung cancer].
Hjelde H; Sundstrøm S; Ødegård A; Hatlinghus S; Abusland AB; Haaverstad R
Tidsskr Nor Laegeforen; 2010 Jan; 130(1):25-8. PubMed ID: 20094119
[TBL] [Abstract][Full Text] [Related]
10. Preoperative pulmonary function as a prognostic factor for stage I non-small cell lung carcinoma.
Iizasa T; Suzuki M; Yasufuku K; Iyoda A; Otsuji M; Yoshida S; Sekine Y; Shibuya K; Saitoh Y; Hiroshima K; Fujisawa T
Ann Thorac Surg; 2004 Jun; 77(6):1896-902; discussion 1902-3. PubMed ID: 15172232
[TBL] [Abstract][Full Text] [Related]
11. Prognostic impact of vascular endothelial growth factor-A and E-cadherin expression in completely resected pathologic stage I non-small cell lung cancer.
Lin Q; Li M; Shen ZY; Xiong LW; Pan XF; Gen JF; Bao GL; Sha HF; Feng JX; Ji CY; Chen M
Jpn J Clin Oncol; 2010 Jul; 40(7):670-6. PubMed ID: 20382636
[TBL] [Abstract][Full Text] [Related]
12. Prognostic impact of intratumoural microvascular invasion and microlymphatic permeation on node-negative non-small-cell lung cancer: which indicator is the stronger prognostic factor?
Hishida T; Yoshida J; Maeda R; Ishii G; Aokage K; Nishimura M; Nagai K
Eur J Cardiothorac Surg; 2013 Apr; 43(4):772-7. PubMed ID: 22864791
[TBL] [Abstract][Full Text] [Related]
13. High transforming growth factor β expression represents an important prognostic parameter for surgically resected non-small cell lung cancer.
Sterlacci W; Wolf D; Savic S; Hilbe W; Schmid T; Jamnig H; Fiegl M; Tzankov A
Hum Pathol; 2012 Mar; 43(3):339-49. PubMed ID: 21840566
[TBL] [Abstract][Full Text] [Related]
14. Charlson Comorbidity Index predicts patient outcome, in cases of inoperable non-small cell lung cancer treated with radiofrequency ablation.
Simon TG; Beland MD; Machan JT; Dipetrillo T; Dupuy DE
Eur J Radiol; 2012 Dec; 81(12):4167-72. PubMed ID: 22835876
[TBL] [Abstract][Full Text] [Related]
15. Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis.
Pelletier MP; Edwardes MD; Michel RP; Halwani F; Morin JE
Can J Surg; 2001 Jun; 44(3):180-8. PubMed ID: 11407827
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of prognostic factors and efficacy of surgical treatment for non-small cell lung cancer: department of surgery NTLDRI (1998-1999)].
Chabowski M; Orłowski TM; Rabczenko D
Pneumonol Alergol Pol; 2008; 76(1):1-10. PubMed ID: 18283649
[TBL] [Abstract][Full Text] [Related]
17. Perioperative anemia and blood transfusions as prognostic factors in patients undergoing resection for non-small cell lung cancers.
Berardi R; Brunelli A; Tamburrano T; Verdecchia L; Onofri A; Zuccatosta L; Gasparini S; Santinelli A; Scartozzi M; Valeri G; Giovagnoni A; Giuseppetti GM; Fabris G; Marmorale C; Fianchini A; Cascinu S
Lung Cancer; 2005 Sep; 49(3):371-6. PubMed ID: 15951051
[TBL] [Abstract][Full Text] [Related]
18. Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension.
Okada M; Sakamoto T; Nishio W; Uchino K; Tsubota N
Cancer; 2003 Aug; 98(3):535-41. PubMed ID: 12879471
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor immunostaining correlates with postoperative relapse and survival in non-small cell lung cancer.
Yilmaz A; Ernam D; Unsal E; Demirag F; Atikcan S; Taştepe I
Arch Med Res; 2007 Oct; 38(7):764-8. PubMed ID: 17845896
[TBL] [Abstract][Full Text] [Related]
20. Do tumours located in the left lower lobe have worse outcomes in lymph node-positive non-small cell lung cancer than tumours in other lobes?
Kudo Y; Saji H; Shimada Y; Nomura M; Usuda J; Kajiwara N; Ohira T; Ikeda N
Eur J Cardiothorac Surg; 2012 Sep; 42(3):414-9. PubMed ID: 22398463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
